86 related articles for article (PubMed ID: 19740398)
1. Aldosterone glucuronidation by human liver and kidney microsomes and recombinant UDP-glucuronosyltransferases: inhibition by NSAIDs.
Knights KM; Winner LK; Elliot DJ; Bowalgaha K; Miners JO
Br J Clin Pharmacol; 2009 Sep; 68(3):402-12. PubMed ID: 19740398
[TBL] [Abstract][Full Text] [Related]
2. Regioselective glucuronidation of gingerols by human liver microsomes and expressed UDP-glucuronosyltransferase enzymes: reaction kinetics and activity correlation analyses for UGT1A9 and UGT2B7.
Wu Z; Liu H; Wu B
J Pharm Pharmacol; 2015 Apr; 67(4):583-96. PubMed ID: 25496264
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the glucuronidating pathway of pectolinarigenin, the major active constituent of the Chinese medicine Daji, in humans and its influence on biological activities.
Liu P; Li Q; Zhu G; Zhang T; Tu D; Zhang F; Finel M; He Y; Ge G
J Ethnopharmacol; 2024 Jan; 319(Pt 1):117280. PubMed ID: 37797876
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of UDP-Glucuronosyltransferase Enzymes by Major Cannabinoids and Their Metabolites.
Nasrin S; Watson CJW; Bardhi K; Fort G; Chen G; Lazarus P
Drug Metab Dispos; 2021 Dec; 49(12):1081-1089. PubMed ID: 34493601
[TBL] [Abstract][Full Text] [Related]
5. Hepatic biotransformation of non-psychotropic phytocannabinoids and activity screening on cytochromes P450 and UDP-glucuronosyltransferases.
Havlasek J; Vrba J; Zatloukalova M; Papouskova B; Modriansky M; Storch J; Vacek J
Toxicol Appl Pharmacol; 2023 Oct; 476():116654. PubMed ID: 37574147
[TBL] [Abstract][Full Text] [Related]
6. Characterization of 17-dihydroexemestane glucuronidation: potential role of the UGT2B17 deletion in exemestane pharmacogenetics.
Sun D; Chen G; Dellinger RW; Sharma AK; Lazarus P
Pharmacogenet Genomics; 2010 Oct; 20(10):575-85. PubMed ID: 20697310
[TBL] [Abstract][Full Text] [Related]
7. Anthraquinone biocolourant dermocybin is metabolized whereas dermorubin is not in in vitro liver fractions and recombinant metabolic enzymes.
Yli-Öyrä J; Juvonen RO; Lehtonen M; Herrala M; Finel M; Räisänen R; Rysä J
Basic Clin Pharmacol Toxicol; 2024 Jun; 134(6):846-857. PubMed ID: 38664998
[TBL] [Abstract][Full Text] [Related]
8. Icaritin exhibits potential drug-drug interactions through the inhibition of human UDP-glucuronosyltransferase in vitro.
Rong Y; Li N; Qiao X; Yang L; Han P; Meng Z; Gan H; Wu Z; Zhu X; Sun Y; Liu S; Dou G; Gu R
Biopharm Drug Dispos; 2024 Jun; 45(3):149-158. PubMed ID: 38886878
[TBL] [Abstract][Full Text] [Related]
9. In vitro inhibitory effects of selumetinib on activity of human UDP-glucuronosyltransferases and prediction of in vivo drug-drug interactions.
Yin H; Lv X; Wang Z; Xiao S; Liang J; Sun J; Jiang L; Liu Y
Toxicol In Vitro; 2024 May; 99():105863. PubMed ID: 38823552
[TBL] [Abstract][Full Text] [Related]
10. The Fusarium metabolite culmorin suppresses the in vitro glucuronidation of deoxynivalenol.
Woelflingseder L; Warth B; Vierheilig I; Schwartz-Zimmermann H; Hametner C; Nagl V; Novak B; Šarkanj B; Berthiller F; Adam G; Marko D
Arch Toxicol; 2019 Jun; 93(6):1729-1743. PubMed ID: 31049613
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective glucuronidation of carvedilol by Chinese liver microsomes.
You LY; Yu CN; Xie SG; Chen SQ; Zeng S
J Zhejiang Univ Sci B; 2007 Oct; 8(10):756-64. PubMed ID: 17910120
[TBL] [Abstract][Full Text] [Related]
12. The Expression Profiles and Deregulation of UDP-Glycosyltransferase (
Hu DG; Marri S; Mackenzie PI; Hulin JA; McKinnon RA; Meech R
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503303
[TBL] [Abstract][Full Text] [Related]
13. Antiseizure properties of fenamate NSAIDs determined in mature human stem-cell derived neuroglial circuits.
Salmanzadeh H; Halliwell RF
Front Pharmacol; 2024; 15():1385523. PubMed ID: 38828453
[TBL] [Abstract][Full Text] [Related]
14. Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).
Knights KM; Rowland A; Miners JO
Br J Clin Pharmacol; 2013 Oct; 76(4):587-602. PubMed ID: 23362865
[TBL] [Abstract][Full Text] [Related]
15. Nanoencapsulated Curcumin Mitigates Liver Injury and Drug-Metabolizing Enzymes Induction in Diclofenac-Treated Mice.
Sunoqrot S; Abu Shalhoob M; Jarrar Y; Hammad AM; Al-Ameer HJ; Al-Awaida W
ACS Omega; 2024 Feb; 9(7):7881-7890. PubMed ID: 38405487
[TBL] [Abstract][Full Text] [Related]
16. The Effects of Pain and Analgesic Medications on Blood Pressure.
Rivasi G; Menale S; Turrin G; Coscarelli A; Giordano A; Ungar A
Curr Hypertens Rep; 2022 Oct; 24(10):385-394. PubMed ID: 35704141
[TBL] [Abstract][Full Text] [Related]
17. Metabolic Basis of Cognitive Improvement Associated With Active B Vitamin Supplementation in Cognitively Impaired Elderly Subjects - A Metabolomics Study.
Zhou H; Wu Y; Jiang B; Li B; Li M; Tian H; Shui G; Lam SM; Kwok T
Front Med (Lausanne); 2022; 9():864152. PubMed ID: 35572970
[TBL] [Abstract][Full Text] [Related]
18. Enzyme Kinetics of Uridine Diphosphate Glucuronosyltransferases (UGTs).
Zhou J; Argikar UA; Miners JO
Methods Mol Biol; 2021; 2342():301-338. PubMed ID: 34272700
[TBL] [Abstract][Full Text] [Related]
19. The Functionality of UDP-Glucuronosyltransferase Genetic Variants and their Association with Drug Responses and Human Diseases.
Jarrar Y; Lee SJ
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34198586
[TBL] [Abstract][Full Text] [Related]
20. Human steroid biosynthesis, metabolism and excretion are differentially reflected by serum and urine steroid metabolomes: A comprehensive review.
Schiffer L; Barnard L; Baranowski ES; Gilligan LC; Taylor AE; Arlt W; Shackleton CHL; Storbeck KH
J Steroid Biochem Mol Biol; 2019 Nov; 194():105439. PubMed ID: 31362062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
